Authors: Merten, OW Cruz, PE Rochette, C Geny-Fiamma, C Bouquet, C Goncalves, D Danos, O Carrondo, MJT

Citation: Ow. Merten et al., Comparison of different bioreactor systems for the production of high titer retroviral vectors, BIOTECH PR, 17(2), 2001, pp. 326-335

Authors: Pizzato, M Merten, OW Blair, ED Takeuchi, Y

Citation: M. Pizzato et al., Development of a suspension packaging cell line for production of high titre, serum-resistant murine leukemia virus vectors, GENE THER, 8(10), 2001, pp. 737-745

Authors: Merten, OW

Citation: Ow. Merten, Safety for vaccine(e)s, CYTOTECHNOL, 34(3), 2000, pp. 181-183

Authors: Merten, OW

Citation: Ow. Merten, Constructive improvement of the ultrasonic separation device ADI 1015, CYTOTECHNOL, 34(1-2), 2000, pp. 175-179

Authors: Merten, OW Kallel, H Manuguerra, JC Tardy-Panit, M Crainic, R Delpeyroux, F Van der Werf, S Perrin, P

Citation: Ow. Merten et al., The new medium MDSS2N, free of any animal protein supports cell growth andproduction of various viruses, CYTOTECHNOL, 30(1-3), 1999, pp. 191-201

Authors: Merten, OW

Citation: Ow. Merten, Special Issue - 15th ESACT-Meeting - Preface - Animal cell technology: Newdevelopments new applications, CYTOTECHNOL, 30(1-3), 1999, pp. IX-IX